- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...
CG Oncology has announced that topline data from its Phase 3 PIVOT-006 trial of intravesical cretostimogene grenadenorepvec in intermediate-risk non-muscle invasive bladder cancer will now be ...
Pivot tables in Microsoft Excel are a great way to organize and analyze data, and the more you know about the feature, the more you’ll get out of it. For instance, filtering a pivot table is a great ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results